Skip to content
10-Q

Quarterly Report

XENETIC BIOSCIENCES, INC. XBIO

0001683168-26-003727

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 2.29M sh
Shares Diluted Q1 2026 · Mar 31, 2026 2.29M sh
Shares Diluted Q1 2026 · Mar 31, 2025 1.54M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$536.38K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $7.35M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $7.88M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $5.16M
Cash And Equivalents Q1 2026 · Dec 31, 2024 $6.17M
Stockholders Equity Q1 2026 · Mar 31, 2026 $6.95M
Stockholders Equity Q1 2026 · Dec 31, 2025 $7.4M
Stockholders Equity Q1 2026 · Mar 31, 2025 $5.12M
Stockholders Equity Q1 2026 · Dec 31, 2024 $6.01M
Current Liabilities Q1 2026 · Mar 31, 2026 $958.24K
Current Liabilities Q1 2026 · Dec 31, 2025 $968.03K
Total Liabilities Q1 2026 · Mar 31, 2026 $958.24K
Total Liabilities Q1 2026 · Dec 31, 2025 $968.03K
Current Assets Q1 2026 · Mar 31, 2026 $7.6M
Current Assets Q1 2026 · Dec 31, 2025 $8.05M
Total Assets Q1 2026 · Mar 31, 2026 $7.91M
Total Assets Q1 2026 · Dec 31, 2025 $8.36M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.20
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.59
Eps Basic Q1 2026 · Mar 31, 2026 −$0.20
Eps Basic Q1 2026 · Mar 31, 2025 −$0.59
Sga Expense Q1 2026 · Mar 31, 2026 $647.6K
Sga Expense Q1 2026 · Mar 31, 2025 $656.64K
Rd Expense Q1 2026 · Mar 31, 2026 $661.44K
Rd Expense Q1 2026 · Mar 31, 2025 $879.03K
Net Income Q1 2026 · Mar 31, 2026 −$456.38K
Net Income Q1 2026 · Mar 31, 2025 −$903.14K
Operating Income Q1 2026 · Mar 31, 2026 −$502.12K
Operating Income Q1 2026 · Mar 31, 2025 −$942.41K
Revenue Q1 2026 · Mar 31, 2026 $806.92K
Revenue Q1 2026 · Mar 31, 2025 $593.26K